Aerial mosquito treatment in Philadelphia to start this week The Philadelphia Section of Environmental Safety has announced that it’ll conduct aerial spraying to control large populations of mosquito larvae in Philadelphia on Mon, June 4. The treatments – – VectoLex CG, which is not a chemical pesticide, but can be a species-specific bacterial agent that targets mosquito and dark fly larvae when added to the water in production areas – – is only going to be employed in areas where sampling shows increased degrees of mosquitoes read more . The prospective areas are huge mosquito habitats for the species that potentially carry the West Nile virus, DEP Southeast Regional Director Joseph A.
Food and Drug Administration , orphan-medication designation for AEZS-108, its doxorubicin targeted conjugate compound, for the treatment of ovarian cancer. AEZS-108 is currently in a Phase 2 trial in advanced ovarian and advanced endometrial tumor in Europe. Juergen Engel, Ph. D., President and CEO of Aeterna Zentaris stated, ‘We are very pleased with AEZS-108 gaining orphan-drug designation for ovarian malignancy from the FDA since it would provide it with extra market exclusivity protection. We look forward to reporting the final outcomes from our ongoing European Stage 2 research in ovarian and endometrial malignancy, later this year.’..